CVE-2024-50405 — MEDIUM (5.5)

Vulnerability Description

An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained administrator access to modify application data. We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later

CVSS Score

5.5

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:N/I:L/A:L

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

HIGH

User Interaction

NONE

Scope

CHANGED

Confidentiality

NONE

Integrity

LOW

Availability

LOW

Affected Products

Vendor	Product	Versions
Qnap	Qts	5.2.0.2737
Qnap	Quts Hero	h5.2.0.2737

Related Weaknesses (CWE)

CWE-94 CWE-93

References

https://www.qnap.com/en/security-advisory/qsa-24-54Vendor Advisory

FAQ

What is CVE-2024-50405?

CVE-2024-50405 is a vulnerability with a CVSS score of 5.5 (MEDIUM). An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote att...

How severe is CVE-2024-50405?

CVE-2024-50405 has been rated MEDIUM with a CVSS base score of 5.5/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2024-50405?

Check the references section above for vendor advisories and patch information. Affected products include: Qnap Qts, Qnap Quts Hero.